4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-25-018759
Chief Operating Officer acquired 4,882 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prince Joshua S. Chief Operating Officer | 2025-06-30 | Grant or award | +4,882 | $1.70 | $8,299 | 10,863 | D |
Loading xslF345X05/form4-07012025_090735.xml…